6242 Share Price Performance
NT$42.00
-2.55 (-5.72%)
Price NT$42.00
Share PriceNT$42.00
6242 Community Narratives
There are no narratives available yet.
Recent 6242 News & Updates
No updates
Li Kang Biomedical Co., Ltd. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 2.56
- Gross Margin
- 68.15%
- Net Profit Margin
- 14.10%
- Debt/Equity Ratio
- 4.0%
Li Kang Biomedical Co., Ltd. Competitors
About 6242
- Founded
- 1982
- Employees
- n/a
- CEO
- WebsiteView website
Li Kang Biomedical Co., Ltd. manufactures and sells supplement, cosmeceutical, and hygienic drink products. It also engages in the management and consulting of tourism factory business; and offers telemarketing services. The company was formerly known as BAFO Technologies Corporation and changed its name to Li Kang Biomedical Co., Ltd. in September 2014. Li Kang Biomedical Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan.
Taiwanese Market Performance
- 7 Days: 0.3%
- 3 Months: 13.8%
- 1 Year: 6.7%
- Year to Date: 2.0%
Over the last 7 days, the market has remained flat, although notably the Energy sector gained 7.6% in that time. As for the longer term, the market has risen 6.7% in the past 12 months. Earnings are forecast to grow by 13% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading